Combo hormone therapy increases risk of breast cancer in women with new-onset tendern

[News]

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.

More... (http://www.news-medical.net/news/20111119/Combo-hormone-therapy-increases-risk-of-breast-cancer-in-women-with-new-onset-tenderness.aspx)